Are you Dr. Winthrop?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 42 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3375 SW Terwilliger Blvd
Portland, OR 97239Phone+1 503-494-7890Fax+1 503-494-0470- Is this information wrong?
Summary
- Dr. Kevin Winthrop, MD is an infectious disease specialist in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Washington, and Florida. He is affiliated with Portland HCS and OHSU Hospital.
Education & Training
- Legacy Health/Emanuel Medical CenterResidency, Internal Medicine, 2004 - 2006
- California Department of Public HealthFellowship, Maxillofacial Pathology, 2002 - 2002
- Oregon Health and Science University School of MedicineClass of 1998
Certifications & Licensure
- CA State Medical License 1999 - Present
- OR State Medical License 2004 - 2025
- WA State Medical License 2024 - 2024
- FL State Medical License 2018 - 2020
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria Start of enrollment: 2012 Apr 19
- A PILOT STUDY OF THE SAFETY AND EFFECTIVENESS OF THE LIVE ZOSTER VACCINE IN ANTI-TNF USERS Start of enrollment: 2014 May 01
- Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) Start of enrollment: 2016 May 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsEULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update.Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B Mc...> ;Annals of the Rheumatic Diseases. 2024 Mar 18
- Risk of Corneal Graft Rejection and Vaccination: A Matched Case-Control Study From a United States Integrated Health Care System.Jennifer H Ku, Afshan A Nanji, Julia E Tubert, Cynthia Joe, Divya Srikumaran, Kevin L Winthrop, Amanda E Brunton, Ana Florea, Frederick Fraunfelder, Tsaiyu Tseng, Y I Luo> ;American Journal of Ophthalmology. 2024 Feb 27
- All you want to know about Mycobacterium abscessus.Emmanuelle Cambau, Giovanni Delogu, Jakko van Ingen, Jean-Louis Herrmann, Kevin Winthrop> ;Clinical Microbiology and Infection. 2024 Feb 23
- Join now to see all
Press Mentions
- JAK Inhibitors Show No Excess Cardiovascular Safety Signal in French Nationwide CohortOctober 20th, 2022
- JAK Inhibitors Show No Excess Cardiovascular Safety Signal in French Nationwide CohortOctober 19th, 2022
- Monoclonal Antibody, Antiviral Therapies Struggle to Keep Pace with COVID-19 VariantsFebruary 11th, 2022
- Join now to see all
Grant Support
- Mycobacterial Disease Prevention: Pharmacovigilance And Inflammatory DiseaseAgency For Healthcare Research And Quality2008–2010
Hospital Affiliations
- Portland HCSPortland, Oregon
- OHSU HospitalPortland, Oregon